Purdue Reformulates OxyContin as "Abuse-Deterrent" After 14 Years, Drives Users to Heroin
On April 5, 2010, the FDA approved Purdue Pharma’s reformulated OxyContin designed to make it more difficult to crush, snort, or inject—14 years after the original drug’s launch and three years after the company’s guilty plea to criminal misbranding. Purdue ceased shipping the old …
Purdue Pharma
FDA
Sackler Family
opioid-crisis
pharmaceutical-industry
regulatory-failure
public-health
unintended-consequences
Read more →